Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)251-256
Number of pages6
JournalPharmacogenomics Journal
Volume13
Issue number3
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-01-39-09-A
  • EMC NIHES-01-64-03

Cite this